FIELD: medicine.
SUBSTANCE: invention refers to medicine, and concerns application of Madopar as a medicinal agent for correction motivation, cognitive and emotional disturbances in autistic spectrum disorders in children.
EFFECT: enhanced correction of motivation, cognitive and emotional disturbances in children with autistic spectrum disorders due to the administration of Madopar.
1 cl, 12 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| APPLICATION OF GLIATILIN AND TRANSCRANIAL MICROPOLARISATION IN TREATMENT OF CHILDREN WITH AUTISTIC DISTURBANCES | 2009 |
|
RU2429831C2 |
| APPLICATION OF TRYPTOPHAN FOR TREATMENT OF PSYCHOVERBAL DEVELOPMENT RETARDATION IN CASE OF NEURO-PSYCHIC DISEASES | 2008 |
|
RU2395279C2 |
| DRUG FOR TREATMENT OF PSYCHOVERBAL DEVELOPMENT RETENTION OF VARIOUS ETIOLOGY | 2007 |
|
RU2333755C1 |
| METHOD OF PSYCHOPATHOLOGICAL ESTIMATION OF PSYCHIC STATE OF INFANTS AND PRESCHOOL CHILDREN | 2012 |
|
RU2497453C1 |
| METHOD OF EVALUATING LIMITATION OF VITAL ACTIVITY OF CHILDREN WITH PSYCHONEUROLOGICAL PROFILE | 2009 |
|
RU2391899C1 |
| METHOD FOR REHABILITATION TREATMENT OF CHILDREN WITH AUTISM SPECTRUM DISORDER | 2022 |
|
RU2792045C1 |
| METHOD OF DETERMINING THE NECESSITY OF USING PSYCHO PHARMACOTHERAPY AMONG THE PATIENTS WITH DISORDERS OF AUTIST SPECTRUM AT THE MOMENT OF THEIR EXAMINATION | 2017 |
|
RU2643760C1 |
| METHOD FOR PREVENTIVE-REHABILITATION CORRECTION OF FUNCTIONAL STATE AND ENHANCEMENT OF BODY ADAPTABILITY | 2013 |
|
RU2557695C2 |
| METHOD OF TREATING ENCEPHALOPATHY IN CHILDREN | 2012 |
|
RU2501584C1 |
| METHOD FOR CLINICO-PSYCHOLOGICAL DIAGNOSTICS OF AFTEREFFECTS OF INSIGNIFICANT PERINATAL LESIONS OF CENTRAL NERVOUS SYSTEM IN CHILDREN AGED 6-10 | 2005 |
|
RU2301687C1 |
